Literature DB >> 9191929

Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes.

K D Ryman1, T N Ledger, R C Weir, J J Schlesinger, A D Barrett.   

Abstract

Two monoclonal antibody neutralization resistant (MAbR) variants of the yellow fever (YF) 17D-204 vaccine virus strain were selected using YF type-specific MAb B39. These B39R variants were compared with the variant virus selected by Lobigs et al. (Virology 161, 474-478, 1987) using a second YF-type specific MAb (2E10) which mapped to amino acid position 71/72 in the envelope (E) protein. Neutralization assays with a panel of MAbs suggested that these two YF-type-specific epitopes are located in two discrete regions of the folded E protein. Each of the B39R variants had a single nucleotide mutation which encoded an amino acid substitution at either position E-155 or E-158. Thus, YF type-specific epitopes map to both domain I (B39) and II (2E10) of the YF virus E protein. The B39 defined epitope represents the first flavivirus neutralizing epitope localized to this region of domain I of the E protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9191929     DOI: 10.1099/0022-1317-78-6-1353

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Molecular characterization of a hamster viscerotropic strain of yellow fever virus.

Authors:  Monica A McArthur; Miguel T Suderman; John-Paul Mutebi; Shu-Yuan Xiao; Alan D T Barrett
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone.

Authors:  T J Chambers; M Nickells
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo.

Authors:  Ana P Goncalvez; Cheng-Hsin Chien; Kamolchanok Tubthong; Inna Gorshkova; Carrie Roll; Olivia Donau; Peter Schuck; Sutee Yoksan; Sy-Dar Wang; Robert H Purcell; Ching-Juh Lai
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

Review 4.  The structural immunology of antibody protection against West Nile virus.

Authors:  Michael S Diamond; Theodore C Pierson; Daved H Fremont
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

5.  Current Assessment of Yellow Fever and Yellow Fever Vaccine.

Authors:  Anabelle Lefeuvre; Philippe Marianneau; Vincent Deubel
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

6.  West Nile virus envelope protein glycosylation is required for efficient viral transmission by Culex vectors.

Authors:  Robin M Moudy; Bo Zhang; Pei-Yong Shi; Laura D Kramer
Journal:  Virology       Date:  2009-02-27       Impact factor: 3.616

7.  Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus.

Authors:  Michael P Doyle; Joseph R Genualdi; Adam L Bailey; Nurgun Kose; Christopher Gainza; Jessica Rodriguez; Kristen M Reeder; Christopher A Nelson; Prashant N Jethva; Rachel E Sutton; Robin G Bombardi; Michael L Gross; Justin G Julander; Daved H Fremont; Michael S Diamond; James E Crowe
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

8.  Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques.

Authors:  Matthew T Aliota; Dawn M Dudley; Christina M Newman; Emma L Mohr; Dane D Gellerup; Meghan E Breitbach; Connor R Buechler; Mustafa N Rasheed; Mariel S Mohns; Andrea M Weiler; Gabrielle L Barry; Kim L Weisgrau; Josh A Eudailey; Eva G Rakasz; Logan J Vosler; Jennifer Post; Saverio Capuano; Thaddeus G Golos; Sallie R Permar; Jorge E Osorio; Thomas C Friedrich; Shelby L O'Connor; David H O'Connor
Journal:  PLoS Negl Trop Dis       Date:  2016-12-02

Review 9.  What Does the Future Hold for Yellow Fever Virus? (II).

Authors:  Raphaëlle Klitting; Carlo Fischer; Jan F Drexler; Ernest A Gould; David Roiz; Christophe Paupy; Xavier de Lamballerie
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

10.  A mouse model for studying viscerotropic disease caused by yellow fever virus infection.

Authors:  Kathryn C Meier; Christina L Gardner; Mikhail V Khoretonenko; William B Klimstra; Kate D Ryman
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.